🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 36269B105
- Market Cap
- Micro Cap
- IPO
- 3/18/2021 · $11.00/share
Business: Gain Therapeutics, Inc. is redefining drug discovery with its See-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding.
Company Contact
- CEO
- Matthias Alder
- CFO
- C. Evan Ballantyne
- Headquarters
- 4800 Hampden Lane, Suite 200, Bethesda, MD 20814
- Phone
- 301-500-1556
- Investor Relations
- Daniel Ferry, LifeSci Advisors · 617-430-7576 · daniel@lifesciadvisors.com